Pharma Mar Sau Stock Today
| PHMMF Stock | USD 75.00 0.00 0.00% |
Performance14 of 100
| Odds Of DistressLess than 9
|
Pharma Mar is trading at 75.00 as of the 4th of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 75.0. Pharma Mar has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Equity ratings for Pharma Mar SAU are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of November 2024 and ending today, the 4th of December 2024. Click here to learn more.
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company has 18.09 M outstanding shares. More on Pharma Mar SAU
Moving against Pharma Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Pharma Pink Sheet Highlights
| Executive Vice Chairman | Pedro Puentes |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Pharma Mar SAU [PHMMF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.26 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharma Mar's market, we take the total number of its shares issued and multiply it by Pharma Mar's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pharma Mar SAU classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 18.09 M outstanding shares.
Pharma Mar SAU has accumulated about 196.7 M in cash with 25.68 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.92.
Check Pharma Mar Probability Of Bankruptcy
Ownership AllocationPharma Mar owns a total of 18.09 Million outstanding shares. Pharma Mar has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Pharma Ownership Details
Pharma Mar SAU Risk Profiles
| Mean Deviation | 1.73 | |||
| Standard Deviation | 4.91 | |||
| Variance | 24.1 | |||
| Risk Adjusted Performance | 0.1451 |
Pharma Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pharma Mar without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Pharma Mar Corporate Management
| Sandra Sanchez | Global Head | Profile | |
| Jos MartinezLosa | Director Relations | Profile | |
| Juan Nogues | Director Sales | Profile | |
| Mara Caballero | Chief Officer | Profile |
Other Information on Investing in Pharma Pink Sheet
Pharma Mar financial ratios help investors to determine whether Pharma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharma with respect to the benefits of owning Pharma Mar security.